AbbVie boosted biotechnology companies with a strong fourth quarter and a greater annual profit forecast, while Pfizer and other drugmakers also made big gains. Intel had its best day in almost nine years after its fourth-quarter results reassured investors that security flaws recently…
News
- Health care, tech and trade hopes lead another stock surge
- Study: Site of 1st chlamydia exposure makes big difference
UT Health San Antonio's schools of medicine, nursing, dentistry, health professions and graduate biomedical sciences have produced more than 33,000 alumni who are advancing their fields throughout the world. With seven campuses in San Antonio and Laredo, UT Health San Antonio has a FY 2018…
- Losses for airlines, tech mostly offset other stock gains
... YORK (AP) — U.S. stocks spent a second day flipping between small gains and losses Thursday as investors again looked for hints about the Trump administration's stance on international trade and the dollar. Major indexes ended the day mixed as airlines plunged while biotech drugmakers…
- EDITOR'S NOTES: How storytelling, science make for compelling evening
“Curing Science to Cure Infection” by Dr. Larry Schlesinger of Texas Biomedical Research Institute ... to capitalize on such resources to attract the brightest minds in research and create a world-class place that fosters innovation and collaboration and is the jewel of San Antonio's bioscience…
- Indexes waver as drugmakers rise and airlines fall further
FILE - In this Friday, Nov. 13, 2015, file photo, the American flag flies above the Wall Street entrance to the New York Stock Exchange. U.S. stocks are mixed early Thursday, Jan. 25, 2018, as health care companies including Biogen and Celgene rise, but airlines continue to take steep losses as…